Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Global Clostridium Difficile Treatment Market 2017-2021


Published on

Market research analysts at Technavio predict that the global clostridium difficile treatment market will grow steadily at a CAGR of over 5% by 2021. This market research analysis identifies the development of novel therapies as one of the primary growth factors for this market. The clostridium difficile infection (CDI) is a leading cause of infectious diarrhea, globally. The recurrence of CDI causes a significant economic burden on the healthcare systems of countries due to a lack of assured outcomes, thereby increasing demand for novel CDI therapies. To address these needs vendors are conducting R&D to develop novel treatments for CDI. For instance, ridinilazole is a novel small molecule antibacterial that is administered orally. It is currently in Phase III of its development cycle. The drug has demonstrated high efficacy during Phase II and is expected to do the same during Phase I. Positive results from Phase III clinical trials can establish the molecule as a differentiated therapy for the treatment of CDI.

The emergence of vaccines is one of the latest trends that will gain traction in the clostridium difficile treatment market in the coming years. The increasing incidence of CDI has encouraged vendors to develop vaccines that prevent CDI and provide long-term protection against it. Additionally, there are several vaccines for CDI that are in various phases of development that are designed to prevent CDI and are cost-effective.

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Global Clostridium Difficile Treatment Market 2017-2021

  1. 1. Global Clostridium Defficile Treatment Market 2017-2021
  2. 2. 2 Scope of this Report01 1. Market landscape, size and forecast 2. Key market highlights 3. Understanding the challenges faced by the market 4. Future market outlook and the roadmap 5. Key focus areas for the vendors 6. Major trends that will shape the future of this market 7. Vendor landscape and trajectory of the market
  3. 3. 3 Growth Rate02 Global clostridium defficile treatment market will grow at a CAGR of more than 5% by 2021.
  4. 4. 4 Key Vendors Featured in this Report03 • Actelion Pharmaceuticals • Merck • Pfizer • Summit Therapeutics Request a Sample
  5. 5. 5 Regions/Countries Covered in this Report04 • Americas • APAC • EMEA View the Report: Global Clostridium Defficile Treatment Market 2017-2021
  6. 6. 6 Key Questions Answered in this Report05 • What will the market size be in 2021? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? Have questions about this report? Contact Us Contact Us
  7. 7. 7 Other Reports You Might be Interested in06 Contact Us Explore our library of 3,000+ insightful, regularly updated reports across niche technology markets and 80+ countries Find Out More > • Global Bone Marrow Transplant Market 2017-2021 • Global Scleroderma Treatment Market 2017-2021 • Global Tinea Pedis Treatment Market 2017-2021
  8. 8. 8 Stay in Touch07 Contact Us Or you can visit us at: North America Chicago, USA Tel: +1 630 333 9501 Fax: +1 630 833 2171 Europe London, United Kingdom Tel: +44 208 123 1770 Fax: +44 845 280 2825 Asia Bangalore, India Tel: +91 803 927 6060 Fax: +91 806 690 2766